Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- PHN—Preparing for Winter Wellness: From Isolation to Intervention: Terrain Telehealth Offers Relief for PHN Sufferers
- 11/7/2025 2:30:32 PM
- For those living with Postherpetic Neuralgia (PHN), isolation often becomes part of the diagnosis. The pain is invisible, misunderstood, and persistent.
- Medicare Expands GLP-1 Coverage as MENU ORDER AI Prepares App Store Debut for the High-Protein / GLP-1 Dining Revolution
- 11/6/2025 10:07:30 PM
- Following news that Medicare will expand coverage for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, MENU ORDER AI is preparing for its App Store debut—timed perfectly to serve the nation’s growing population of GLP-1 users and health-conscious diners.
- Intertek expands ATIC footprint in Central America with acquisition of leading Costa Rican testing business Suplilab
- 11/6/2025 11:02:23 AM
- • Fast-growing Costa Rican economy is driving a strong demand for Risk-based Quality Assurance services in food safety and medical device testing sectors • Suplilab is a high-quality ATIC provider with a leading scale position and a track record of fast growth in high-margin sectors • Acquisition of Suplilab gives Intertek immediate access to attractive ATIC growth …
- AdvaMed Welcomes Bipartisan, Bicameral Congressional Diabetes Caucus Concerns Over Draft Medicare Competitive Bidding Proposal
- 11/6/2025 10:38:59 AM
- AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and U.S.
- Study finds radiotherapy can be avoided after a mastectomy
- 11/6/2025 5:19:29 AM
- An international trial found that patients with early-stage breast cancer who underwent a mastectomy, removal of the breast, had similar 10-year survival rates whether or not they received radiotherapy.
- WHO and Bayer AG renew longstanding collaboration to eliminate three deadly neglected tropical diseases
- 11/4/2025 10:25:30 AM
- The World Health Organization (WHO) and the German pharmaceutical company, Bayer AG, have renewed a longstanding collaboration to support endemic countries in scaling up free-of-charge treatment against three deadly neglected tropical diseases (NTDs). Since 2002, Bayer AG has been donating medicines in support of WHO’s work on NTDs, which is now managed by the …
- Telehealth & Medicine Today Appoints Dr. Suhail Chughtai as Editor-in-Chief
- 11/4/2025 8:00:00 AM
- Telehealth and Medicine Today (THMT), the leading open access, peer reviewed journal exploring innovations in telehealth, virtual care, and digital medicine, is pleased to announce the appointment of Dr.
- PHN Month Spotlight: PainBreak® Delivers Terrain-Wide Relief for Chronic Nerve Pain
- 10/30/2025 11:44:00 AM
- For those living with Postherpetic Neuralgia (PHN), pain is more than a symptom—it’s a terrain-wide disruption. Burning, stabbing, and electric sensations can persist long after shingles fade, leaving patients disoriented, depleted, and misdiagnosed.
- Archy Raises $20M Series B to Put Dental Practices on Autopilot
- 10/30/2025 10:01:18 AM
- Archy, an AI platform that puts dental practices on autopilot, today announced $20 million in Series B funding led by TCV along with Bessemer Venture Partners, CRV, Entrée Capital, and 25 practicing dentists.
- PHN Month Continues: Terrain-Based Questionnaire Empowers Patients to Assess Disruption and Guide Healing
- 10/29/2025 12:52:06 PM
- For those living with postherpetic neuralgia (PHN), pain often defies explanation. A soft breeze, a cotton shirt, even a hug can trigger unbearable discomfort.
- California employers, meet our smarter Choice plan
- 10/29/2025 10:47:48 AM
- Kaiser Permanente is primarily known for our highly rated HMO plans. Enter Kaiser Permanente Plus.™ We designed this commercial product to bring some provider flexibility to the quality and value of our integrated care offering.
- Indomo Launches Out of Stealth with $25M to Bring Instant, At-Home Acne Injections to Consumers
- 10/29/2025 9:00:00 AM
- Imagine this: just as one breakout finally starts to heal, another inflamed pimple surfaces – red, swollen, and impossible to ignore. They always seem to arrive at the worst times, whether before a client meeting, a first date, or school picture day.
- PHN Unmasked: Terrain-Based Healing Offers New Hope for Chronic Nerve Pain
- 10/28/2025 10:08:08 AM
- As Postherpetic Neuralgia (PHN) Month concludes, Postherpetic Neuralgia Consulting is sounding a bold alarm: chronic nerve pain after shingles isn’t just a lingering symptom—it’s a terrain-wide disruption demanding a radically different healing approach.
- Weaving health through learning: WHO Academy brings Pacific Open Learning Health Net back online
- 10/27/2025 10:47:06 AM
- The World Health Organization (WHO) announced the revitalization of the Pacific Open Learning Health Net (POLHN), which will soon be available as a dedicated learning space on the WHO Academy online learning platform.
- AMA, Ad Council launch firearm injury prevention digital resource hub
- 10/24/2025 11:01:55 AM
- With firearm injuries the leading cause of death of children and teens in the U.S., the American Medical Association (AMA) and the Ad Council, in collaboration with a coalition of health care leaders, launched a new digital resource hub at AgreeToAgree.org/HealthCare to empower physicians and other health care professionals to confidently and compassionately engage …
- Dr. Uma Naidoo Joins Outro Health to Advance Integrative Nutritional and Lifestyle Psychiatry for People Ready to Taper Off Antidepressants
- 10/24/2025 9:00:00 AM
- Outro Health is proud to announce that Dr. Uma Naidoo, a best-selling author, Harvard-trained psychiatrist, chef, nutritionist, and named “America’s Nutritional Psychiatrist” by the press, has joined the company as a Nutrition & Lifestyle Medicine Advisor.
- Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
- 10/22/2025 10:09:19 AM
- Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study • Efdoralprin alfa demonstrated superiority in a head-to-head study versus a standard of care plasma-derived therapy • Results reinforce the potential of efdoralprin alfa to be the first restorative recombinant therapy that normalizes and …
- AMA launches Center for Digital Health and AI
- 10/22/2025 10:01:50 AM
- The American Medical Association (AMA) announced the launch of its Center for Digital Health and AI, a new endeavor created to put physicians at the center of shaping, guiding, and implementing technologies transforming medicine.
- Elsevier Expands Geographical Pricing for Open Access to support greater participation in global research
- 10/22/2025 10:00:37 AM
- Elsevier, a global leader in advanced information and decision support in science and healthcare, is expanding its Geographical Pricing for Open Access (GPOA) initiative to an additional 150 gold open access journals, following the success of its 2024 pilot.
- Kaiser Permanente health plans earn high 2026 Medicare Star Ratings
- 10/22/2025 9:58:35 AM
- Kaiser Permanente’s Medicare Advantage health plans are highly rated, according to the Centers for Medicare & Medicaid Services 2026 Star Ratings.